6-106629703-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018292.5(QRSL1):āc.22G>Cā(p.Glu8Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000578 in 1,453,880 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018292.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
QRSL1 | NM_018292.5 | c.22G>C | p.Glu8Gln | missense_variant, splice_region_variant | 1/11 | ENST00000369046.8 | NP_060762.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
QRSL1 | ENST00000369046.8 | c.22G>C | p.Glu8Gln | missense_variant, splice_region_variant | 1/11 | 1 | NM_018292.5 | ENSP00000358042.4 | ||
QRSL1 | ENST00000369044.1 | c.22G>C | p.Glu8Gln | missense_variant, splice_region_variant | 1/7 | 2 | ENSP00000358040.1 | |||
QRSL1 | ENST00000467262.1 | n.105G>C | splice_region_variant, non_coding_transcript_exon_variant | 1/4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000904 AC: 21AN: 232180Hom.: 0 AF XY: 0.000111 AC XY: 14AN XY: 125800
GnomAD4 exome AF: 0.0000578 AC: 84AN: 1453880Hom.: 1 Cov.: 32 AF XY: 0.0000678 AC XY: 49AN XY: 722270
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | The c.22G>C (p.E8Q) alteration is located in exon 1 (coding exon 1) of the QRSL1 gene. This alteration results from a G to C substitution at nucleotide position 22, causing the glutamic acid (E) at amino acid position 8 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 08, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with QRSL1-related conditions. This variant is present in population databases (rs376227484, gnomAD 0.01%). This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 8 of the QRSL1 protein (p.Glu8Gln). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at